Victor Sandor

2018

In 2018, Victor Sandor earned a total compensation of $2.9M as Chief Medical Officer at Array BioPharma, a 17% increase compared to previous year.

Compensation breakdown

Bonus$5,000
Non-Equity Incentive Plan$273,489
Option Awards$1,607,598
Salary$474,127
Stock Awards$526,890
Other$13,836
Total$2,900,940

Sandor received $1.6M in option awards, accounting for 55% of the total pay in 2018.

Sandor also received $5K in bonus, $273.5K in non-equity incentive plan, $474.1K in salary, $526.9K in stock awards and $13.8K in other compensation.

Rankings

In 2018, Victor Sandor's compensation ranked 3,997th out of 14,244 executives tracked by ExecPay. In other words, Sandor earned more than 71.9% of executives.

ClassificationRankingPercentile
All
3,997
out of 14,244
72nd
Division
Manufacturing
1,472
out of 5,765
75th
Major group
Chemicals And Allied Products
523
out of 2,128
75th
Industry group
Drugs
439
out of 1,817
76th
Industry
Pharmaceutical Preparations
340
out of 1,391
76th
Source: SEC filing on September 14, 2018.

Sandor's colleagues

We found four more compensation records of executives who worked with Victor Sandor at Array BioPharma in 2018.

2018

Ron Squarer

Array BioPharma

Chief Executive Officer

2018

Curtis Oltmans

Array BioPharma

General Counsel

2018

Andrew Robbins

Array BioPharma

Chief Operating Officer

2018

Jason Haddock

Array BioPharma

Chief Financial Officer

News

In-depth

You may also like